0001213900-19-016453.txt : 20190821 0001213900-19-016453.hdr.sgml : 20190821 20190821163304 ACCESSION NUMBER: 0001213900-19-016453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190820 FILED AS OF DATE: 20190821 DATE AS OF CHANGE: 20190821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tesi Raymond Joseph CENTRAL INDEX KEY: 0001767280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 191043373 MAIL ADDRESS: STREET 1: 476 MASSACHUSETTS AVE, UNIT 2 CITY: BOSTON STATE: MA ZIP: 02118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2019-08-20 0 0001711754 Inmune Bio, Inc. INMB 0001767280 Tesi Raymond Joseph C/O INMUNE BIO INC., 1200 PROSPECT STREET, SUITE 525 LA JOLLA CA 92037 1 1 1 0 President & CEO Common Stock 2019-08-20 4 P 0 100 5.96 A 1539033 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539133 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539233 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539333 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539433 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539533 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539633 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539733 D Common Stock 2019-08-20 4 P 0 100 5.96 A 1539833 D Common Stock 2019-08-20 4 P 0 100 5.9239 A 1539933 D Common Stock 2019-08-20 4 P 0 1000 6.0308 A 1540933 D The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions. /s/ Raymond Joseph Tesi 2019-08-21